StockData
Clover Health Investments, Corp. logo

Clover Health Investments, Corp. (CLOV) company profile

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

About Clover Health Investments

Hospital & Medical Service Plans, SIC 6324

Clover Health operates as a healthcare technology and insurance company focused on empowering physicians with proprietary software to detect, manage, and treat chronic conditions. Its primary insurance offerings include Medicare Advantage Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans, alongside specialized programs like Clover Home Care for complex patients. The company also offers Counterpart Assistant, a clinician-centric software-as-a-service and technology-enabled platform licensed to external payors and providers. Clover Health primarily serves Medicare-eligible beneficiaries, particularly seniors with chronic diseases and individuals residing in historically underserved communities.

As of January 1, 2026, the company operates its Medicare Advantage plans across five states and 203 counties. As of December 31, 2025, Clover Health employs 724 individuals located primarily in the United States and Hong Kong. Operating under a remote-first organizational model, Clover Health does not maintain a corporate headquarters.

Summary of the business section of Clover Health Investments's latest annual report, written by StockData.

Company profile

Company

Legal name
Clover Health Investments, Corp.
Founded
2019
Headquarters
Jersey City, NJ
Address
30 Montgomery Street 07302
Phone
(201) 432-2133
Employees
724, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, New York, New York

Stock & identifiers

Ticker
CLOV
Former tickers
IPOC until Mar 31, 2021
Exchange
Nasdaq
IPO date
Apr 23, 2020
Shares outstanding
531M, Jul 31, 2026
Public float
$1.13B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
19-for-3, May 17, 2021
SEC CIK
1801170
CUSIP
18914F103
ISIN
US18914F1030
FIGI
BBG00SHY90J5
Share class FIGI
BBG00SHY90K3
LEI
5493000HLYOYQU6LK133
EIN
98-1515192

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Andrew ToyChief Executive Officer, Director9,078,334
Joseph Frank OldakowskiChief Accounting Officer462,300
Joseph Clay ThorntonChief Financial Officer1,573,882
Jamie L. ReynosoCEO, Medicare Advantage2,770,351
Karen SoaresChief Legal Officer1,573,423
Conrad WaiCEO, Counterpart Health2,212,128
Brady Patrick PriestCEO of Clover Care Services2,040,222
Peter J. KuipersChief Financial Officer5,758,353
Robert G. TorricelliDirector186,897
Brian James MillerDirector12,481
Carladenise Armbrister EdwardsDirector285,432
Vivek GaripalliDirector95,687,832
Thomas L. TranDirector180,029
William G. Robinson JrDirector597,987
Demetrios L. KouzoukasDirector605,980
Anna U. LoengardDirector584,666
Lee ShapiroDirector598,622
Chelsea ClintonDirector602,814

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$1.32M-$3.08M$1.48M$15$96
FY2024$9.48M$23.94M$3.29M$20$78
FY2023$10.15M$10.67M$1.68M$6$79
FY2022$0-$39.38M$9.28M$6$74
FY2021$389.57M$62.37M$37.03M$23$93

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Andrew Toy
Co-Founder and Chief Executive Officer
$800.00K–$509.54K$9.85K$1.32M-86%
Peter Kuipers
Chief Financial Officer
$525.00K$1.18M$344.14K–$2.05M-59%
Jamie L. Reynoso
Chief Executive Officer of Medicare Advantage
$550.00K–$904.63K$13.54K$1.47M-69%
Conrad Wai
Chief Executive Officer of Counterpart Health
$495.00K–$704.46K$12.48K$1.21M-73%
Brady Priest
Chief Executive Officer of Clover Care Services
$495.00K–$704.46K–$1.20M-73%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Apr 23, 2020
Offer price
$10.00
Securities offered
72,000,000
Gross proceeds
$720.00M
Exchange
NYSE
First trading day
Jun 12, 2020
First-day close
$10.20+2.0%
Lock-up ends (est.)
Dec 9, 2020

“Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“At December 31, 2025, we had 724 employees with approximately 93% in the U.S.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?